synucleinopathy

Literature (15)

Literature for DOID 0050890: synucleinopathy

Xenbase Articles Publications associated with this Disease Ontology entry or its descendants

:
(

Denotes literature images)

Identification and molecular cloning of Xenopus laevis SP22, a protein associated with fertilization in mammals., Monetti C,Vigetti D,Gornati R,Prati M,Klinefelter GR,Bernardini G, Comp Biochem Physiol B Biochem Mol Biol. August 1, 2002; 132(4):1096-4959.
The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease., Camargo SM,Vuille-dit-Bille RN,Mariotta L,Ramadan T,Huggel K,Singer D,Götze O,Verrey F, J Pharmacol Exp Ther. October 1, 2014; 351(1):1521-0103.
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway., Salašová A,Yokota C,Potěšil D,Zdráhal Z,Bryja V,Arenas E, Mol Neurodegener. July 11, 2017; 12(1):1750-1326.
Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease., Stahl K,Rahmani S,Prydz A,Skauli N,MacAulay N,Mylonakou MN,Torp R,Skare Ø,Berg T,Leergaard TB,Paulsen RE,Ottersen OP,Amiry-Moghaddam M, PLoS One. January 1, 2018; 13(3):1932-6203.
HCN2 Rescues brain defects by enforcing endogenous voltage pre-patterns., Pai VP,Pietak A,Willocq V,Ye B,Shi NQ,Levin M, Nat Commun. March 8, 2018; 9(1):2041-1723.
Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors., Sandager-Nielsen K,Ahring PK,Klein J,van Hout M,Thaneshwaran S,Dos Santos AB,Jacobsen TA,Amrutkar DV,Peters D,Jensen AA,Kohlmeier KA,Christophersen P,Dyhring T, Biochem Pharmacol. April 1, 2020; 174:1873-2968.
Voltage-Dependent Dopamine Potency at D1-Like Dopamine Receptors., Ågren R,Sahlholm K, Front Pharmacol. April 7, 2020; 11:1663-9812.
Xenopus leads the way: Frogs as a pioneering model to understand the human brain., Exner CRT,Willsey HR, Genesis. February 1, 2021; 59(1-2):1526-968X.
WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels., An D,Peigneur S,Tytgat J, Biomedicines. April 28, 2021; 9(5):2227-9059.
Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation., Drouyer M,Bolliger MF,Lobbestael E,Van den Haute C,Emanuele M,Lefebvre R,Sibran W,De Wit T,Leghay C,Mutez E,Dzamko N,Halliday GM,Murayama S,Martoriati A,Cailliau K,Bodart JF,Chartier-Harlin MC,Baekelandt V,Nichols RJ,Taymans JM, Neurobiol Dis. September 1, 2021; 157:1095-953X.
Influence of Sox protein SUMOylation on neural development and regeneration., Chang KC, Neural Regen Res. March 1, 2022; 17(3):1673-5374.
A role for zinc transporter gene SLC39A12 in the nervous system and beyond., Davis DN,Strong MD,Chambers E,Hart MD,Bettaieb A,Clarke SL,Smith BJ,Stoecker BJ,Lucas EA,Lin D,Chowanadisai W, Gene. October 5, 2021; 799:1879-0038.
Translocation of TMEM175 Lysosomal Potassium Channel to the Plasma Membrane by Dynasore Compounds., Pergel E,Veres I,Csigi GI,Czirják G, Int J Mol Sci. September 29, 2021; 22(19):1422-0067.
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease., Iovino L,Giusti V,Pischedda F,Giusto E,Plotegher N,Marte A,Battisti I,Di Iacovo A,Marku A,Piccoli G,Bandopadhyay R,Perego C,Bonifacino T,Bonanno G,Roseti C,Bossi E,Arrigoni G,Bubacco L,Greggio E,Hilfiker S,Civiero L, Acta Neuropathol. July 1, 2022; 144(1):1432-0533.
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC,Kambara K,Bertrand D, Expert Opin Drug Discov. February 1, 2024; 19(2):1746-045X.

Identification and molecular cloning of Xenopus laevis SP22, a protein associated with fertilization in mammals., Monetti C,Vigetti D,Gornati R,Prati M,Klinefelter GR,Bernardini G, Comp Biochem Physiol B Biochem Mol Biol. August 1, 2002; 132(4):1096-4959.

The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease., Camargo SM,Vuille-dit-Bille RN,Mariotta L,Ramadan T,Huggel K,Singer D,Götze O,Verrey F, J Pharmacol Exp Ther. October 1, 2014; 351(1):1521-0103.

A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway., Salašová A,Yokota C,Potěšil D,Zdráhal Z,Bryja V,Arenas E, Mol Neurodegener. July 11, 2017; 12(1):1750-1326.

Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease., Stahl K,Rahmani S,Prydz A,Skauli N,MacAulay N,Mylonakou MN,Torp R,Skare Ø,Berg T,Leergaard TB,Paulsen RE,Ottersen OP,Amiry-Moghaddam M, PLoS One. January 1, 2018; 13(3):1932-6203.

HCN2 Rescues brain defects by enforcing endogenous voltage pre-patterns., Pai VP,Pietak A,Willocq V,Ye B,Shi NQ,Levin M, Nat Commun. March 8, 2018; 9(1):2041-1723.

Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors., Sandager-Nielsen K,Ahring PK,Klein J,van Hout M,Thaneshwaran S,Dos Santos AB,Jacobsen TA,Amrutkar DV,Peters D,Jensen AA,Kohlmeier KA,Christophersen P,Dyhring T, Biochem Pharmacol. April 1, 2020; 174:1873-2968.

Voltage-Dependent Dopamine Potency at D1-Like Dopamine Receptors., Ågren R,Sahlholm K, Front Pharmacol. April 7, 2020; 11:1663-9812.

Xenopus leads the way: Frogs as a pioneering model to understand the human brain., Exner CRT,Willsey HR, Genesis. February 1, 2021; 59(1-2):1526-968X.

WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels., An D,Peigneur S,Tytgat J, Biomedicines. April 28, 2021; 9(5):2227-9059.

Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation., Drouyer M,Bolliger MF,Lobbestael E,Van den Haute C,Emanuele M,Lefebvre R,Sibran W,De Wit T,Leghay C,Mutez E,Dzamko N,Halliday GM,Murayama S,Martoriati A,Cailliau K,Bodart JF,Chartier-Harlin MC,Baekelandt V,Nichols RJ,Taymans JM, Neurobiol Dis. September 1, 2021; 157:1095-953X.

Influence of Sox protein SUMOylation on neural development and regeneration., Chang KC, Neural Regen Res. March 1, 2022; 17(3):1673-5374.

A role for zinc transporter gene SLC39A12 in the nervous system and beyond., Davis DN,Strong MD,Chambers E,Hart MD,Bettaieb A,Clarke SL,Smith BJ,Stoecker BJ,Lucas EA,Lin D,Chowanadisai W, Gene. October 5, 2021; 799:1879-0038.

Translocation of TMEM175 Lysosomal Potassium Channel to the Plasma Membrane by Dynasore Compounds., Pergel E,Veres I,Csigi GI,Czirják G, Int J Mol Sci. September 29, 2021; 22(19):1422-0067.

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease., Iovino L,Giusti V,Pischedda F,Giusto E,Plotegher N,Marte A,Battisti I,Di Iacovo A,Marku A,Piccoli G,Bandopadhyay R,Perego C,Bonifacino T,Bonanno G,Roseti C,Bossi E,Arrigoni G,Bubacco L,Greggio E,Hilfiker S,Civiero L, Acta Neuropathol. July 1, 2022; 144(1):1432-0533.

Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC,Kambara K,Bertrand D, Expert Opin Drug Discov. February 1, 2024; 19(2):1746-045X.